Hypermethylation in the BNIP3 promoter occurs in a majority of tumors, including pancreatic cancer [18], hepatocellular carcinoma [36], colon cancer [35], and gastric cancer [37]. Here, BNIP3 is linked to malignant colon neoplasm.